newleos-therapeutics
(2)Legend
Legend
Founder · Investor · Operator
David Donabedian and the art of handing over the keys
He has helped start companies, raise their first capital, and recruit the people who take them forward. At Newleos, David Donabedian’s move from founding CEO to advisor fits a career built around the beginning.
david-donabedian · newleos-therapeuticsRead →
Executive · Operator · Founder
Timothy Noyes
Timothy Noyes is the President and CEO of Newleos Therapeutics, a Boston clinical-stage biotech that raised an oversubscribed $93.5M Series A to revive four neuropsychiatric compounds shelved by Roche. A Harvard-trained operator with three decades in biopharma, he has taken Proteon and Aerovate public, launched Renagel at GelTex/Genzyme, and built teams that carry molecules from bench to late-stage trials.
timothy-noyes · newleos-therapeuticsRead →